AMANF yields 4.77% · JNJ yields 2.13%● Live data
📍 AMANF pulled ahead of the other in Year 1
Combined, AMANF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AMANF + JNJ for your $10,000?
Amano Corporation provides time information, parking, environmental, and cleaning systems in Japan, North America, and internationally. It operates through Time Information System Business and Environment System Business segments. The company's time information systems include time and attendance (T&A), payroll, human resource, and access information systems; and T&A and access information terminals, PC interfaced time recorders, time recorders, electronic time stamps, and T&A/payroll/HR cloud services. It also provides parking systems, such as gate-type, flap-lock, bicycle parking, vehicle guidance, parking lot management, and security gate systems, as well as offers parking facility data center and commissioned management services. In addition, the company offers environmental systems comprising energy and space-saving pulse-jet, all stainless steel body, and dust explosion pressure diffusion type dust collectors; electric mist collectors; dust collectors for welding work; industrial air purifiers; and volatile organic compounds removal, pneumatic powder conveying, and large-scale dust collection systems. Further, it provides cleaning systems that include compact automatic floor and ride-on automatic scrubbers; robotic vacuum, carpet, and industrial vacuum cleaners; and electrolytic water generators, electronic high-speed burnishers, hand-pushed sweepers, and floor polishers. Amano Corporation was founded in 1931 and is headquartered in Yokohama, Japan.
Full AMANF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.